Oscar Health, Inc. (OSCR) Q3 2022 Earnings Call Transcript

Oscar Health, Inc. (NYSE:OSCR) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET

Company Participants

Cornelia Miller - Vice President, Corporate Development and Investor Relations
Mario Schlosser - Co-Founder and Chief Executive Officer
Scott Blackley - Chief Financial Officer
Sid Sankaran - Interim Chief Financial Officer

Conference Call Participants

Connor Massari - Morgan Stanley
Stephen Baxter - Wells Fargo
Nathan Rich - Goldman Sachs
Josh Raskin - Nephron Research

Operator

Good afternoon. My name is Josh and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health’s 2022 Third Quarter Conference Call. [Operator Instructions] Thank you. I would now like to turn it over to Cornelia Miller, Vice President of Corporate Development and Investor Relations, to begin the conference.

Cornelia Miller

Thank you, Josh and good afternoon everyone. Thank you for joining us for our third quarter 2022 earnings call, where we will discuss our performance to-date, our path to profitability and the recently announced management transition.

Mario Schlosser, Oscar’s Co-Founder and Chief Executive Officer; and Scott Blackley, Oscar’s Chief Financial Officer and soon-to-be Chief Transformation Officer, will host this afternoon’s call, which can also be accessed through our Investor Relations website at ir.hioscar.com. Full details of our results and additional management commentary are available in our earnings release, which can be found on our Investor Relations website at ir.hioscar.com.

Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our quarterly report on Form 10-Q for the quarterly period ended June 30, 2022 filed with the SEC and our other